Literature DB >> 7977784

Anti-AP-1 activity of all-trans retinoic acid in glomerular mesangial cells.

M S Simonson1.   

Abstract

Functional antagonism between retinoic acid (RA) receptors and activator protein-1 (AP-1) transcription factors might regulate expression of genes involved in the response to injury in the kidney. We designed experiments to analyze the mechanisms by which RA inhibits AP-1-directed transcriptional responses in glomerular mesangial cells. RA inhibited serum-stimulated mesangial cell proliferation as assessed by measurements of [3H]thymidine uptake and cell number. In transient transfection assays with a chloramphenicol acetyltransferase reporter, RA completely blocked transcription directed by an AP-1 cis-element in cells stimulated by serum. AP-1 DNA binding was analyzed in electrophoretic gel mobility shift assays using nuclear extracts from control or RA-pretreated cells stimulated with serum. RA did not abolish AP-1 DNA binding activity under the conditions of this assay. The apparent equilibrium dissociation constant, maximal density of binding, and association rate for the AP-1-DNA interaction were similar in serum-stimulated cells or RA-pretreated cells stimulated with serum. RA repressed serum-stimulated induction of the immediate early genes c-fos and c-jun, whose protein products dimerize to form AP-1. Repression was relatively selective for c-fos/c-jun; induction of other immediate early transcription factors (junB, c-myc, and egr-1) was not downregulated by RA. That repression of c-fos by RA might contribute to anti-AP-1 activity was suggested by experiments with an antisense c-fos expression vector, which demonstrated that c-fos induction was required for serum-stimulated AP-1 activity. Together, these data demonstrate that RA antagonizes AP-1-directed transcription without inhibiting AP-1 DNA-binding in mesangial cells. Selective repression of c-fos and c-jun might contribute to the anti-AP-1 activity of RA.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7977784     DOI: 10.1152/ajprenal.1994.267.5.F805

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  13 in total

1.  Therapeutics in renal disease: the road ahead for antiproliferative targets.

Authors:  Peter J Nelson; Stuart J Shankland
Journal:  Nephron Exp Nephrol       Date:  2005-12-07

2.  Amelioration of glomerulosclerosis with all-trans retinoic acid is linked to decreased plasminogen activator inhibitor-1 and α-smooth muscle actin.

Authors:  Xia Liu; Lei Lü; Bei-bei Tao; Ai-ling Zhou; Yi-chun Zhu
Journal:  Acta Pharmacol Sin       Date:  2011-01       Impact factor: 6.150

3.  Sensitization of human umbilical vein endothelial cells to Shiga toxin: involvement of protein kinase C and NF-kappaB.

Authors:  C B Louise; M C Tran; T G Obrig
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

4.  Retinoic acid inhibits HIV-1-induced podocyte proliferation through the cAMP pathway.

Authors:  John Cijiang He; Ting-Chi Lu; Margaret Fleet; Masaaki Sunamoto; Mohammad Husain; Wei Fang; Susana Neves; Yibang Chen; Stuart Shankland; Ravi Iyengar; Paul E Klotman
Journal:  J Am Soc Nephrol       Date:  2006-12-20       Impact factor: 10.121

5.  Human renal mesangial cells are a target for the anti-inflammatory action of 9-cis retinoic acid.

Authors:  V M Manzano; J C Muñoz; J R Jiménez; M R Puyol; D R Puyol; M Kitamura; F J Cazaña
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

6.  13-cis retinoic acid inhibits development and progression of chronic allograft nephropathy.

Authors:  Judith Adams; Eva Kiss; Ana B V Arroyo; Mahnaz Bonrouhi; Qiang Sun; Zhen Li; Norbert Gretz; Anna Schnitger; Christos C Zouboulis; Manfred Wiesel; Jürgen Wagner; Peter J Nelson; Hermann-Josef Gröne
Journal:  Am J Pathol       Date:  2005-07       Impact factor: 4.307

7.  Retinoic acid utilizes CREB and USF1 in a transcriptional feed-forward loop in order to stimulate MKP1 expression in human immunodeficiency virus-infected podocytes.

Authors:  Ting-Chi Lu; Zhaohui Wang; Xiaobei Feng; Peter Chuang; Wei Fang; Yibang Chen; Susana Neves; Avi Maayan; Huabao Xiong; Yusen Liu; Ravi Iyengar; Paul E Klotman; John Cijiang He
Journal:  Mol Cell Biol       Date:  2008-07-14       Impact factor: 4.272

8.  Suppression of postischemic hippocampal nerve growth factor expression by a c-fos antisense oligodeoxynucleotide.

Authors:  J K Cui; C Y Hsu; P K Liu
Journal:  J Neurosci       Date:  1999-02-15       Impact factor: 6.167

9.  Retinoic acid receptor alpha and retinoid X receptor specific agonists reduce renal injury in established chronic glomerulonephritis of the rat.

Authors:  Matthias Schaier; Sabine Liebler; Kerstin Schade; Fujio Shimizu; Hiroshi Kawachi; Hermann-Joseph Grone; Roshantha Chandraratna; Eberhard Ritz; Juergen Wagner
Journal:  J Mol Med (Berl)       Date:  2004-01-08       Impact factor: 4.599

10.  AKR1B10 is induced by hyperglycaemia and lipopolysaccharide in patients with diabetic nephropathy.

Authors:  Nicholas Shaw; Bingmei Yang; Ann Millward; Andrew Demaine; Andrea Hodgkinson
Journal:  Cell Stress Chaperones       Date:  2013-08-23       Impact factor: 3.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.